ASH News Daily 2012 - Monday, December 10, 2012 - (Page B-1)

ASH NewS DAily ® 54th Annual Meeting of the American Society of Hematology Read this issue online at www.hematology.org/ashnewsdaily2012_monday Schedule 7:00 a.m. – 5:00 p.m. Registration GWCC ASH Central 7:00 – 8:30 a.m. Education Program 10:00 a.m. – 2:00 p.m. Exhibit Hall Open GWCC Hall B3-B4 10:00 a.m. – 8:00 p.m. Poster Session III – Viewing GWCC Hall B1-B2 10:30 a.m. – 12:00 noon Education Program 10:30 a.m. – 12:00 noon Education Spotlight Sessions (ticketed sessions) 12:00 noon – 1:30 p.m. Open Time for Lunch (A light lunch will be provided in the Exhibit Hall.) GWCC Hall B3-B4 12:15 – 1:15 p.m. Trainee Simultaneous Didactic Sessions Open to trainees wearing a blue badge only 2:45 – 4:15 p.m. Education Program 2:45 – 4:15 p.m. Education Spotlight Sessions (ticketed sessions) 6:00 – 8:00 p.m. Poster Session III – Presentations GWCC Hall B1-B2 6:00 – 8:00 p.m. Poster Hall Reception GWCC Hall B1-B2 his morning at 9:00, Timothy J. Ley, MD, Washington University School of Medicine, will deliver the 2012 E. Donnall Thomas Lecture, “The AML Genome.” The lecture and prize are named after the late Nobel Prize Laureate and past Society president E. Donnall Thomas, MD, celebrating an individual whose research achievements have caused a fundamental change in the field of hematology. Dr. Ley’s lecture will explore the use of whole-genome sequencing in acute myeloid leukemia (AML), which has offered an unprecedented view of the mutations that cause this disease. He will also discuss next-generation DNA-sequencing approaches, which provide detailed information about the clonal architecture of AML at various stages and may shed light on the progression of the disease and the reasons behind drug resistance. Dr. Ley was the 2008 winner of the ASH Mentor Award in Basic Science. T Expert in AML to Deliver Thomas Lecture and directs the Embryonic Stem Cell Core at Washington University’s Siteman Cancer Center. In fact, it was at this Institute last July that Dr. Ley and his team made headlines when they fully sequenced the genes of cancerous and comparatively healthy cells in one of their own colleagues who had been diagnosed with leukemia. (Dr. Ley talks more about this below.) Dr. Ley continues to work on the AML genome with hopes of identifying and understanding all of the mutations that cause the disease. Recently, ASH News Daily spoke with Dr. Ley about some of his biggest challenges, best advice, and favorite pastimes. Q: What does this honorific award represent to you? Dr. Ley: Don Thomas always personified excellence and integrity in science: He will be greatly missed. Anything associated with his name, »» THOMAS LECTURE Page B-8 Timothy J. Ley, MD He holds the Lewis T. and Rosalind B. Apple Chair in Oncology, serves as chief of the Section of Stem Cell Biology in the Division of Oncology, and is professor of medicine and genetics at Washington University. He also serves as associate director of The Genome Institute (for Cancer Genomics) Karen Bunting, PhD, Receives 2012 Joanne Levy Memorial Award aren Bunting, PhD, of Weill Cornell Medical College in New York, is the recipient of the 2012 Joanne Levy, MD, Memorial Award for Outstanding Achievement. This award is presented to the ASH Scholar Award recipient with the highest-scoring abstract for the ASH annual meeting, as determined by the appointed Karen Bunting, PhD abstract reviewers. The memorial award honors the memory honors, including the ASH Junior and legacy of past Scholar Award re- Faculty Scholar Award in 2000. cipient and respected member of the Dr. Bunting remarked, “This Society, Joanne Levy, who passed award means a great deal to me away in 2004. ASH is honored to of- personally, and I am truly grateful fer this award, made possible by the for the support of the Levy family Levy family. and hope that our ongoing research Dr. Levy graduated from Har- into the processes that underpin hevard Medical School and went on to matopoiesis will continue Joanne receive many esteemed awards and Levy’s legacy in this field.” She also K IN THIS SECTION ASH International Programs Intersect in Dar es Salaam B-5 ASH Resources and Tools for Clinicians B-10 Scholar Award Recipients B-14 Exploring Atlanta B-37 commented that the award “acknowledges a highly successful collaborative effort between a group of dedicated biologists and computational scientists, highlighting the fact that a team approach is the most powerful way to tackle a scientific question.” Dr. Bunting, a postdoctoral associate in the Department of Medicine/HematologyMedical Oncology at Weill Cornell, she obtained her bachelor’s of biomedical science from the University of Adeliade, South Australia. She went on to pursue an honors degree in the Infectious Disease Laboratories, IMVS, where she studied the pathogenesis of hemorrhagic forms of dengue virus, and »» LEVY MEMORIAL AWARD Page B-6  http://www.hematology.org/ashnewsdaily2012_monday

Table of Contents for the Digital Edition of ASH News Daily 2012 - Monday, December 10, 2012

ASH News Daily 2012 - Monday, December 10, 2012

https://www.nxtbookmedia.com